Alpha Teknova, Inc. (TKNO) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

22/25

Growth 5 Margin 5 Expansion 5 Platform 3 Financial 4

latest quarter score

Earnings Reports

22
Technova (TKNO) Q2 2026: Revenue Jumps 18% as Custom Product Demand and AI Tools Expand Growth Path
August 06, 2026
15
TechNova (TKNO) Q1 2026: Clinical Solutions Revenue Surges 85% as Diversified Demand Signals Inflection
May 07, 2026
19
Technova (TKNO) Q4 2025: Clinical Solutions Revenue Jumps 47% as Biotech Pipeline Builds
February 27, 2026
13
Technova (TKNO) Q3 2025: Lab Essentials Up 16% as Custom Biopharma Remains Soft
November 07, 2025
18
Technova (TKNO) Q2 2025: Clinical Solutions Up 32% as Custom Pipeline Expands
August 08, 2025
18
Technova (TKNO) Q1 2025: Lab Essentials Revenue Climbs 12% as Core Growth Reasserts
July 05, 2025
Teknova (TKNO) Q4 2024: Clinical Solutions Revenue Doubles, Signaling Growth Inflection
March 04, 2025

Browse all companies